Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
Infinimmune logo — Treating human disease with truly human therapeutics.

Infinimmune

Treating human disease with truly human therapeutics.

Founded 2022 United States Alameda, United States 16 employees Seed Total: $12.00M Biotechnology, Health Care +1

General Information

Company Name Infinimmune
Founded Year 2022
Location United States Alameda, United States
Employees 16
Industries Biotechnology, Health Care, Life Sciences
Funding Stage Seed
Social

BounceWatch is an independent company data service, not affiliated with Infinimmune. To contact Infinimmune, visit infinimmune.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Infinimmune compare?

A PDF of Infinimmune and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Infinimmune soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Infinimmune

Infinimmune is a promising startup in the biotechnology and healthcare industries, founded in 2022. The company's mission, as reflected in its slogan "Treating human disease with truly human therapeutics," is to revolutionize the treatment of human diseases. In December 2022, Infinimmune secured a significant $12.00M Seed Round investment, drawing support from a notable group of investors including Pear Ventures, Civilization Ventures, Playground Global, Axial VC, Ron Alfa, Paul Conley, Benjamin Kim, Joshua Meier, and Jacob Becraft. This substantial investment reflects the investor confidence in Infinimmune's innovative approach and potential to make substantial contributions to the healthcare industry. With its headquarters in the United States, Infinimmune is poised to make waves in the field of human therapeutics and significantly impact the world of medicine.

Business keywords: antibody discovery, therapeutics, human immune system, drug development

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round $12.00M 9
Pear Ventures Civilization Ventures Playground Global
Pear Ventures, Civilization Ventures +7
06 Dec 2022

Infinimmune Alternatives & Competitors

Infinimmune vs
Ability Biotherapeutics
Ability Biotherapeutics Canada

Developing innovative targeted immuno therapeutics to addressing unmet medical needs for cancer and...

Seed
25 employees
Biotechnology, Life Sciences
Infinimmune vs
Tradewind BioScience
Tradewind BioScience United States

Innovative therapeutics for the most aggressive cancers

Seed
5 employees
Biotechnology, Health Care
Infinimmune vs
Cidara Therapeutics
Cidara Therapeutics United States

Leading the Science of Protection

Acquired
47 employees
Biotechnology, Health Care

FAQ About Infinimmune

Treating human disease with truly human therapeutics.
Infinimmune was founded in 2022.
Infinimmune is headquartered in Alameda, United States.
Infinimmune operates in Biotechnology, Health Care and Life Sciences. Its work centres on antibody discovery, therapeutics, human immune system and drug development.
Infinimmune has approximately 16 employees.
Infinimmune has completed 1 funding round, raising a total of $12.00M. The latest funding stage is Seed.
Top alternatives and competitors to Infinimmune include Ability Biotherapeutics, Tradewind BioScience, Cidara Therapeutics, Merus N.V., Mestag Therapeutics. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Infinimmune and Ability Biotherapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Infinimmune, https://bouncewatch.com/company/infinimmune, updated 4 July 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes